Table 3.
Outcomes | Model I | Model II | Model III | |||
---|---|---|---|---|---|---|
OR(95% CI) | P | OR(95% CI) | P | OR(95% CI) | P | |
FT3/FT4 (quartile) | ||||||
Q1 (≥0.26, and<0.40) | Ref | <0.001 | Ref | <0.001 | Ref | <0.001 |
Q2 (≥0.40, and<0.44) | 1.478(1.258~1.736) | <0.001 | 1.343(1.112~1.623) | 0.002 | 1.285(1.049~1.573) | 0.015 |
Q3 (≥0.44, and<0.49) | 1.863(1.589~2.183) | <0.001 | 1.589(1.317~1.915) | <0.001 | 1.336(1.090~1.636) | 0.005 |
Q4 (≥0.49, and≤0.80) | 2.624(2.238~3.077) | <0.001 | 2.002(1.661~2.414) | <0.001 | 1.533(1.250~1.879) | <0.001 |
P for trend | <0.001 | <0.001 | <0.001 | |||
TT3RI (quartile) | ||||||
Q1 (≥2.48, and<7.31) | Ref | <0.001 | Ref | <0.001 | Ref | <0.001 |
Q2 (≥7.31, and<10.19) | 1.443(1.231~1.691) | <0.001 | 1.299(1.078~1.565) | 0.006 | 1.239(1.014~1.513) | 0.036 |
Q3 (≥10.19, and<14.23) | 1.361(1.161~1.595) | <0.001 | 1.080(0.896~1.302) | 0.420 | 0.974(0.796~1.191) | 0.794 |
Q4 (≥14.23, and≤33.97) | 1.765(1.506~2.069) | <0.001 | 1.473(1.223~1.774) | <0.001 | 1.268(1.037~1.549) | 0.021 |
P for trend | <0.001 | <0.001 | 0.087 | |||
TFQIFT3 (quartile) | ||||||
Q1(≥-1.00, and<-0.28) | Ref | <0.001 | Ref | <0.001 | Ref | <0.001 |
Q2(≥-0.28, and<0.00) | 1.670(1.415~1.970) | <0.001 | 1.455(1.200~1.764) | <0.001 | 1.320(1.075~1.620) | 0.008 |
Q3(≥0.00, and<0.28) | 1.917(1.626~2.259) | <0.001 | 1.596(1.317~1.934) | <0.001 | 1.300(1.059~1.596) | 0.012 |
Q4(≥0.28, and≤1.00) | 2.769(2.352~3.260) | <0.001 | 1.985(1.640~2.403) | <0.001 | 1.521(1.239~1.866) | <0.001 |
P for trend | <0.001 | <0.001 | <0.001 |
Notes: Model 1 was adjusted for age and gender; Model 2 was adjusted for the covariates of model 1 plus WC, BMI, SBP, DBP; Model 3 was adjusted for the covariates of model 2 plus TC, TG, LDL-C, HDL-C, FPG, BUN, SUA, Scr, AST and ALT.